 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis |
| Sung Eun Kim, Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi, |
|
Korean J Helicobacter Up Gastrointest Res. 2021;21(1):48-58. Published online January 28, 2021 DOI: https://doi.org/10.7704/kjhugr.2020.0052 |
|
Meta-Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First-Line Therapy for Helicobacter pylori Eradication Helicobacter. 2009;14(5):449-459  Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days Helicobacter. 2011;16(4):295-300 Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis Helicobacter. 2011;16(2):131-138 High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication Helicobacter. 2010;15(3):233-238 Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori Gastroenterology. 2011;140(5):S-880 Su1694 Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori Gastroenterology. 2012;142(5):S-483 Twice‐daily intake of bismuth‐based quadruple therapy for first‐line Helicobacter pylori eradication: A retrospective study on 10‐day, 14‐day, and half‐dose antibiotic therapy Helicobacter. 2023;28(4): A modified Bismuth-Containing Quadruple Therapy Including a Short Course of Furazolidone for Helicobacter pylori Eradication After Sequential Therapy Failure Helicobacter. 2012;17(4):264-268 Mo1101 Comparison of the Efficacy of 10 Day-Triple Therapy-Based, Bismuth-Containing Quadruple Therapy With Sequential Therapy for First-Line Therapy of Helicobacter pylori Gastroenterology. 2014;146(5):S-557 High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment Medicine. 2019;98(7):e14396 |
